378 related articles for article (PubMed ID: 33965186)
1. Haploidentical Peripheral Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide and Methotrexate.
Yang K; Gong S; Jiang T; Liang X; Hu J; Zhu P; Nie L; Xu Y; Fu B;
Transplant Cell Ther; 2021 May; 27(5):429.e1-429.e7. PubMed ID: 33965186
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
[TBL] [Abstract][Full Text] [Related]
4. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.
DeZern AE; Zahurak M; Symons H; Cooke K; Jones RJ; Brodsky RA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):498-504. PubMed ID: 28013015
[TBL] [Abstract][Full Text] [Related]
5. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation.
Wu L; Zhou M; Li Y; Chen X; Mo W; Wang C; Xu S; Zhou W; Deng T; Zhou R; Pan S; Wang S; Zhang Y
Transplant Cell Ther; 2023 Jul; 29(7):463.e1-463.e7. PubMed ID: 37098408
[TBL] [Abstract][Full Text] [Related]
6. Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
George B; Pn N; Devasia AJ; Kulkarni U; Korula A; Lakshmi KM; Abraham A; Srivastava A; Mathews V
Biol Blood Marrow Transplant; 2018 Mar; 24(3):494-500. PubMed ID: 29100905
[TBL] [Abstract][Full Text] [Related]
7. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome.
Nakaya Y; Koh H; Konuma T; Shimomura Y; Ishiyama K; Itonaga H; Hino M; Doki N; Nishida T; Ohigashi H; Matsuoka KI; Kanda Y; Maruyama Y; Sawa M; Eto T; Hiramoto N; Fukuda T; Atsuta Y; Nakamae H
Transplant Cell Ther; 2024 Mar; 30(3):316.e1-316.e12. PubMed ID: 38108263
[TBL] [Abstract][Full Text] [Related]
8. Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China.
Gong S; Chen C; Chen K; Yang R; Wang L; Yang K; Hu J; Nie L; Su T; Xu Y; He X; Yang L; Xiao H; Fu B
Transplant Cell Ther; 2023 Jan; 29(1):48.e1-48.e7. PubMed ID: 36272527
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
11. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
[TBL] [Abstract][Full Text] [Related]
12. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
[TBL] [Abstract][Full Text] [Related]
13. Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India.
Kharya G; Jaiswal SR; Bhat S; Raj R; Yadav SP; Dua V; Sen S; Bakane A; Badiger S; Uppuluri R; Rastogi N; Sachdev M; Sharma B; Saifullah A; Chakrabarti S
Transplant Cell Ther; 2023 Mar; 29(3):199.e1-199.e10. PubMed ID: 36572385
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
Zu Y; Zhou J; Fu Y; Fang B; Liu X; Zhang Y; Yu F; Zuo W; Zhou H; Gui R; Li Z; Liu Y; Zhao H; Zhang C; Song Y
Sci Rep; 2021 Jan; 11(1):253. PubMed ID: 33420287
[TBL] [Abstract][Full Text] [Related]
15. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
[TBL] [Abstract][Full Text] [Related]
16. Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Rappazzo KC; Zahurak M; Bettinotti M; Ali SA; Ambinder AJ; Bolaños-Meade J; Borrello I; Dezern AE; Gladstone D; Gocke C; Fuchs E; Huff CA; Imus PH; Jain T; Luznik L; Rahmat L; Swinnen LJ; Wagner-Johnston N; Jones RJ; Ambinder RF
Transplant Cell Ther; 2021 Nov; 27(11):909.e1-909.e6. PubMed ID: 34425261
[TBL] [Abstract][Full Text] [Related]
17. High Failure-Free Survival after Unrelated Donor Peripheral Blood Stem Cell Transplantation in Pediatric Severe Aplastic Anemia.
Yoo JW; Kim S; Lee JW; Jang PS; Jeong DC; Cho B; Chung NG
Transplant Cell Ther; 2022 Feb; 28(2):103.e1-103.e8. PubMed ID: 34823062
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of combination of HLA-haploidentical hematopoietic SCT with an unrelated cord blood unit for 127 patients with acquired severe aplastic anemia].
Liu LM; Zhang YM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):624-628. PubMed ID: 30180460
[No Abstract] [Full Text] [Related]
19. Successful engraftment of haploidentical bone marrow with post-transplantation cyclophosphamide in patients with aplastic anemia.
Dang BN; De Oliveira S; Gray A; Bowles L; Moore TB
Pediatr Transplant; 2020 Mar; 24(2):e13652. PubMed ID: 31944531
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience.
Li Y; Wang N; Li L; Cao Y; Xu J; Wang J; Huang L; Wang L; Zou L; Wang H; Xiao Y; Wei J; Zhang Y
Transplant Cell Ther; 2021 Apr; 27(4):331.e1-331.e7. PubMed ID: 33836879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]